Sources of variability in ketoconazole inhibition of human cytochrome P450 3A in vitro

By Greenblatt David J.   Venkatakrishnan Karthik   Harmatz Jerold S.   Parent Sarah J.   von Moltke Lisa L.  

Xenobiotica, Vol. 40, Iss. 10, 2010-10 ,pp. : 713-720

Informa Healthcare

Access to resources Recommend Favorite

In vitro assessment of metabolic drug–drug interaction potential of AZD2624, neurokinin-3 receptor antagonist, through cytochrome P₄₅₀ enzyme identification, inhibition, and induction studies

By Li Yan   Zhou Diansong   Ferguson Stephen S.   Dorff Peter   Simpson Thomas R.   Grimm Scott W.  

Xenobiotica, Vol. 40, Iss. 11, 2010-11 ,pp. : 721-729

Informa Healthcare

Access to resources Recommend Favorite

In vitro modulation of naturally occurring flavonoids on cytochrome P450 2A6 (CYP2A6) activity

By Tiong K.H.   Yiap B.C.   Tan E.L.   Ismail R.   Ong C.E.  

Xenobiotica, Vol. 40, Iss. 7, 2010-07 ,pp. : 458-466

Informa Healthcare

Access to resources Recommend Favorite

Prediction of in vivo drug interactions with eplerenone in man from in vitro metabolic inhibition data

By Cook C. S.   Berry L. M.   Burton E.  

Xenobiotica, Vol. 34, Iss. 3, 2004-03 ,pp. : 215-228

Informa Healthcare

Access to resources Recommend Favorite

In vitro inhibition and induction of human cytochrome P450 enzymes by mirabegron, a potent and selective β3-adrenoceptor agonist

By Takusagawa Shin   Miyashita Aiji   Iwatsubo Takafumi   Usui Takashi  

Xenobiotica, Vol. 42, Iss. 12, 2012-12 ,pp. : 1187-1196

Informa Healthcare

Access to resources Recommend Favorite